Related Experiment Video
Updated: Aug 4, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Should non-patient volunteers donate eggs?
M R Rimington1, K K Ahuja, E G Simons
1Cromwell IVF and Fertility Centre, Cromwell Hospital, Cromwell Road, London SW5 0TU, UK.
Reproductive Biomedicine Online
|May 9, 2003
Summary
Egg sharing offers an ethical and efficient alternative to traditional egg donation, minimizing risks for healthy donors. This method ensures comparable pregnancy success rates while optimizing egg utilization.
Area of Science:
- Reproductive Medicine
- Human Embryology
- Bioethics
Background:
- Egg donation encompasses commercial, altruistic, and egg-sharing models, each with inherent medical and surgical risks for donors.
- Egg sharing uniquely avoids transforming healthy egg donors into patients, differentiating it from other donation methods.
Purpose of the Study:
- To evaluate egg sharing as a safe, ethical, and efficient model for anonymous egg donation.
- To compare pregnancy outcomes and risks associated with egg sharing versus traditional egg donation programs.
Main Methods:
- Analysis of outcomes from a program utilizing carefully selected egg-share donors.
- Review of ethical considerations and regulatory frameworks (e.g., Human Fertilisation and Embryology Authority - HFEA) for anonymous egg donation.
Main Results:
- Egg sharing demonstrates comparable pregnancy rates for both donors and recipients to established egg donation programs.
- This model achieves greater efficiency by utilizing a single cohort of eggs for both parties.
- Egg sharing minimizes risks by not subjecting healthy donors to invasive procedures solely for donation.
Conclusions:
- Anonymous egg sharing, regulated by the HFEA, presents a low-risk, ethically sound approach to egg donation.
- It is proposed as the sole acceptable method for anonymous egg donation due to its balanced benefits and minimized risks.
Keywords:
Genetics and ReproductionRelated Concept Videos
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

